TNFRSF1A Gene Periodic Fever Autosomal Dominant Genetic Test
Welcome to DNA Labs UAE, where we offer comprehensive genetic testing services. In this blog, we will be discussing the TNFRSF1A gene periodic fever autosomal dominant genetic test, its cost, symptoms, diagnosis, and more.
Test Name: TNFRSF1A Gene Periodic Fever Autosomal Dominant Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Before undergoing the TNFRSF1A gene periodic fever autosomal dominant genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with periodic fever autosomal dominant.
Test Details
The TNFRSF1A gene is associated with a condition called periodic fever syndrome. This condition is characterized by recurrent episodes of fever and inflammation. The TNFRSF1A gene provides instructions for making a protein called tumor necrosis factor receptor superfamily member 1A, which plays a role in regulating immune system responses.
Periodic fever syndrome can be inherited in an autosomal dominant manner, meaning that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. To diagnose periodic fever syndrome, we use NGS (next-generation sequencing) technology for genetic testing. This type of genetic testing allows for the simultaneous analysis of multiple genes or the entire exome or genome in a person’s DNA.
By analyzing the TNFRSF1A gene using NGS genetic testing, our doctors can identify specific mutations or variations that may be associated with periodic fever syndrome. This information is crucial for diagnosis, prognosis, and treatment decisions for individuals with this condition.
If you suspect that you or your family member may have periodic fever syndrome, we recommend undergoing the TNFRSF1A gene periodic fever autosomal dominant genetic test. Early diagnosis and appropriate treatment can significantly improve the quality of life for affected individuals.
For more information or to schedule an appointment, please contact DNA Labs UAE.
Test Name | TNFRSF1A Gene Periodic fever autosomal dominant Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TNFRSF1A Gene Periodic fever autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Periodic fever autosomal dominant |
Test Details |
The TNFRSF1A gene is associated with a condition called periodic fever syndrome, which is characterized by recurrent episodes of fever and inflammation. This gene provides instructions for making a protein called tumor necrosis factor receptor superfamily member 1A, which is involved in regulating immune system responses. Periodic fever syndrome can be inherited in an autosomal dominant manner, which means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. NGS (next-generation sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire exome (all protein-coding genes) or genome (all genes) in a person’s DNA. It can help identify specific mutations or variations in genes, including the TNFRSF1A gene, that may be associated with periodic fever syndrome. By analyzing the TNFRSF1A gene using NGS genetic testing, doctors can identify mutations or variations that may be causing periodic fever syndrome. This information can help with diagnosis, prognosis, and treatment decisions for individuals with this condition. |